Hematuria interventions

Jump to navigation Jump to search

Hematuria Microchapters

Home

Patient Information

Overview

Definition

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hematuria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hematuria interventions On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hematuria interventions

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hematuria interventions

CDC on Hematuria interventions

Hematuria interventions in the news

Blogs on Hematuria interventions

Directions to Hospitals Treating Hematuria

Risk calculators and risk factors for Hematuria interventions

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2] Steven C. Campbell, M.D., Ph.D. Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [3]

Overview

A procedure called plasmapheresis may sometimes be used for glomerulonephritis caused by immune problems.

Indications

A procedure called plasmapheresis may sometimes be used for glomerulonephritis caused by immune problems. The fluid part of the blood that contains antibodies is removed and replaced with intravenous fluids or donated plasma (that does not contain antibodies). Removing antibodies may reduce inflammation in the kidney tissues. However, the mainstay of treatment for hematuria usually depends on the underlying etiology.[1][2]

References

  1. Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M (March 1999). "Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children". Am J Kidney Dis. 33 (3): 427–33. doi:10.1016/s0272-6386(99)70178-2. PMID 10070905.
  2. Coppo R, Basolo B, Giachino O, Roccatello D, Lajolo D, Mazzucco G, Amore A, Piccoli G (1985). "Plasmapheresis in a patient with rapidly progressive idiopathic IgA nephropathy: removal of IgA-containing circulating immune complexes and clinical recovery". Nephron. 40 (4): 488–90. doi:10.1159/000183527. PMID 4022221.

Template:WH Template:WS